Recently, the AIMTB Assay produced by Leide Biosciences Co., Ltd. has obtained registration certificates issued by NMPA, and will be officially commercialize in China domestic market
Learn more+On August 19, 2019, LDEBIO received a B round of strategic investment from Kingmed capital with an amount of more than 50 million yuan.
RA_CP, an early RA ELISA diagnostic kit with a new international biomarker has been launched
Recently, a new international marker, rheumatoid arthritis citrullinated protein detection kit (RA_CP), innovatively developed by Leide Bioscience Co., Ltd. ("LDEBIO" for short) has obtained the National Medical Device Registration ...
Official WeChat Add：7D, Science & Technology Innovation Base, #80 Lanyue Road, Huangpu District, Guangzhou, P.R.China